These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19734935)

  • 1. Exogenous p27KIP1 expression induces anti-tumour effects and inhibits the EGFR/PI3K/Akt signalling pathway in PC3 cells.
    Chen J; Xia D; Luo JD; Wang P
    Asian J Androl; 2009 Nov; 11(6):669-77. PubMed ID: 19734935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI3K/Akt signaling regulates p27(kip1) expression via Skp2 in PC3 and DU145 prostate cancer cells, but is not a major factor in p27(kip1) regulation in LNCaP and PC346 cells.
    van Duijn PW; Trapman J
    Prostate; 2006 May; 66(7):749-60. PubMed ID: 16425184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sox2 targets cyclinE, p27 and survivin to regulate androgen-independent human prostate cancer cell proliferation and apoptosis.
    Lin F; Lin P; Zhao D; Chen Y; Xiao L; Qin W; Li D; Chen H; Zhao B; Zou H; Zheng X; Yu X
    Cell Prolif; 2012 Jun; 45(3):207-16. PubMed ID: 22469032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PI3K/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer.
    Prasad SB; Yadav SS; Das M; Modi A; Kumari S; Pandey LK; Singh S; Pradhan S; Narayan G
    Cell Oncol (Dordr); 2015 Jun; 38(3):215-25. PubMed ID: 25821107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.
    Zhao Z; Li C; Xi H; Gao Y; Xu D
    Mol Med Rep; 2015 Oct; 12(4):5415-22. PubMed ID: 26166196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of p27 sensitize to dual PI3K/mTOR inhibition.
    Lee M; Theodoropoulou M; Graw J; Roncaroli F; Zatelli MC; Pellegata NS
    Mol Cancer Ther; 2011 Aug; 10(8):1450-9. PubMed ID: 21646547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The death domain-containing kinase RIP1 regulates p27(Kip1) levels through the PI3K-Akt-forkhead pathway.
    Park S; Ramnarain DB; Hatanpaa KJ; Mickey BE; Saha D; Paulmurugan R; Madden CJ; Wright PS; Bhai S; Ali MA; Puttaparthi K; Hu W; Elliott JL; Stuve O; Habib AA
    EMBO Rep; 2008 Aug; 9(8):766-73. PubMed ID: 18566599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ephrin type‑A receptor 2 regulates sensitivity to paclitaxel in nasopharyngeal carcinoma via the phosphoinositide 3‑kinase/Akt signalling pathway.
    Wang Y; Liu Y; Li G; Su Z; Ren S; Tan P; Zhang X; Qiu Y; Tian Y
    Mol Med Rep; 2015 Feb; 11(2):924-30. PubMed ID: 25351620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brassinin induces G1 phase arrest through increase of p21 and p27 by inhibition of the phosphatidylinositol 3-kinase signaling pathway in human colon cancer cells.
    Izutani Y; Yogosawa S; Sowa Y; Sakai T
    Int J Oncol; 2012 Mar; 40(3):816-24. PubMed ID: 22307336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity.
    Busse D; Doughty RS; Ramsey TT; Russell WE; Price JO; Flanagan WM; Shawver LK; Arteaga CL
    J Biol Chem; 2000 Mar; 275(10):6987-95. PubMed ID: 10702262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential epidermal growth factor receptor signaling regulates anchorage-independent growth by modulation of the PI3K/AKT pathway.
    Humtsoe JO; Kramer RH
    Oncogene; 2010 Feb; 29(8):1214-26. PubMed ID: 19935697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.
    Wong MH; Xue A; Julovi SM; Pavlakis N; Samra JS; Hugh TJ; Gill AJ; Peters L; Baxter RC; Smith RC
    Clin Cancer Res; 2014 Aug; 20(15):4047-58. PubMed ID: 24895459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway.
    Gesbert F; Sellers WR; Signoretti S; Loda M; Griffin JD
    J Biol Chem; 2000 Dec; 275(50):39223-30. PubMed ID: 11010972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
    Festuccia C; Muzi P; Millimaggi D; Biordi L; Gravina GL; Speca S; Angelucci A; Dolo V; Vicentini C; Bologna M
    Endocr Relat Cancer; 2005 Dec; 12(4):983-98. PubMed ID: 16322337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
    Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
    Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective action of liraglutide in beta cells under lipotoxic stress via PI3K/Akt/FoxO1 pathway.
    Shao S; Nie M; Chen C; Chen X; Zhang M; Yuan G; Yu X; Yang Y
    J Cell Biochem; 2014 Jun; 115(6):1166-75. PubMed ID: 24415347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis.
    Chen J; Wang W; Wang H; Liu X; Guo X
    Drug Discov Ther; 2014 Feb; 8(1):33-41. PubMed ID: 24647156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galangin Induces Apoptosis in MCF-7 Human Breast Cancer Cells Through Mitochondrial Pathway and Phosphatidylinositol 3-Kinase/Akt Inhibition.
    Liu D; You P; Luo Y; Yang M; Liu Y
    Pharmacology; 2018; 102(1-2):58-66. PubMed ID: 29879712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3K/Akt pathway.
    Li GQ; Xie J; Lei XY; Zhang L
    World J Gastroenterol; 2009 Nov; 15(44):5541-8. PubMed ID: 19938192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.